Longevity 2026: Why the Field Is Finally Facing Clinical Reality
Longevity is growing up. In 2026, the field is finally being judged by trials, endpoints, and clinical reality.
Longer lives. Better years. What the science actually says.
Longevity is growing up. In 2026, the field is finally being judged by trials, endpoints, and clinical reality.
Ca-AKG studies measure different things. New mouse results and human clock data show why a biological-age reading cannot promise a longer life.
How should you read a glycine sleep claim? A source-based guide to study design, useful comparisons, and the questions a supplement label leaves open.
What should a Mitopure claim have to prove? A source-based guide to reading trial endpoints, comparing formulations, and evaluating a supplement listing.
Body Scan combines estimates, an ECG, and wellness scores. Each needs its own interpretation, intended-use limits, and model-specific precautions.
Longevity research is becoming more credible, but the fantasy of optional death still moves much faster than the science.
Klotho is not interesting because aging has been solved with one shot. It is interesting because it forces longevity to face the hard realities of gene-therapy translation.
The real longevity story by 2030 is not a miracle leap to 120. It is a harder transition where diagnostics, selective interventions, and unequal access move faster than grand promises.